Jens Hoffmann
- Oncology top 5%
- Cancer Cells and Metastasis 13
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 11
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 15
- Cancer, Hypoxia, and Metabolism 9
- Biotechnology top 5%
- Cancer Research and Treatments 7
-
- Lung Cancer Treatments and Mutations 10
- Molecular Biology top 10%
-
- Estrogen and related hormone effects 10
- Co-authors
- Iduna FichtnerAnette SommerMartin R. SchneiderUlrich KlarHelmut KlockerIris E. EderMichael W. BeckerKarsten Parczyk
- Cited by
- OncologyCancer ResearchBiotechnology
- Journals
- Cancer Research (7 papers)International Journal of Cancer (6 papers)Advances in experimental medicine and biology (5 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Jens Hoffmann
111 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 117
- Oncology 950
- Cancer Research 520
- Biotechnology 194
- Pulmonary and Respiratory Medicine 610
- Molecular Biology 1.0k
Countries citing papers authored by Jens Hoffmann
This map shows the geographic impact of Jens Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Hoffmann more than expected).
Fields of papers citing papers by Jens Hoffmann
This network shows the impact of papers produced by Jens Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Hoffmann. The network helps show where Jens Hoffmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jens Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 19 | |
| 4 | 2020 | 43 | |
| 5 | 2020 | 6 | |
| 6 | 2017 | 9 | |
| 7 | 2013 | 2 | |
| 8 | 2010 | 34 | |
| 9 | 2010 | 30 | |
| 10 | 2010 | 12 | |
| 11 | 2008 | 227 | |
| 12 | 2005 | 7 | |
| 13 | 2005 | 27 | |
| 14 | New synthetic Epothilone Derivative ZK-EPO inhibits breast cancer metastasis | 2005 | 6 |
| 15 | Diagnostik und Therapie des M. Crohn | 2003 | 0 |
| 16 | 2003 | 35 | |
| 17 | 1999 | 0 | |
| 18 | Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas. | 1999 | 17 |
| 19 | 1994 | 2 | |
| 20 | Trichilia hispida(センダン科)の成分 IV 二種の新チルカラントリテルペノイド,ヒスピドールA及びB | 1981 | 35 |
About Jens Hoffmann
Jens Hoffmann is a scholar working on Cancer Research, Oncology, Biotechnology, Biophysics and Cell Biology, having authored 117 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (15 papers), Cancer Cells and Metastasis (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (11 papers), Estrogen and related hormone effects (10 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Cancer Research and Treatments (7 papers). The work is most often cited by research in Oncology (950 citations), Cancer Research (520 citations), Biotechnology (194 citations), Pulmonary and Respiratory Medicine (610 citations) and Molecular Biology (1.0k citations). Jens Hoffmann has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Iduna Fichtner, Anette Sommer, Martin R. Schneider, Ulrich Klar, Helmut Klocker, Iris E. Eder, Michael W. Becker, Karsten Parczyk, Johannes Merk and Jana Rolff. Their work appears in journals such as Cancer Research, International Journal of Cancer, Advances in experimental medicine and biology, Clinical Cancer Research and The Journal of Steroid Biochemistry and Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.